Drug Patent Watch

MAY 18, 2024

ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.

Pharmaceuticals 64

Pharmaceuticals Drugs 64

Drugs.com

MAY 18, 2024

SATURDAY, May 18, 2024 -- People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes, nose or throat.But they often aren’t aware that.

59

59

Collaborative Drug

MAY 18, 2024

Upcoming Webinar: Targeted Protein Degradation - New Modalities and Design Technologies

Targeted Protein Degradation 86

Targeted Protein Degradation 86

Drug Patent Watch

MAY 18, 2024

Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

MAY 18, 2024

Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

MAY 18, 2024

This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59